Merck & Co Supply Chain
Supply Chain of Merck & Co (MRK) as of Oct 9, 2026.
Get this data via API
Financial Data API
Supply Chain
-
Last updated:
Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.
Merck & Co Supply Chain
Correlation: how closely stock prices move together
Same directionNo relationOpposite
191 companies
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.78 | 0.77 | 0.73 | ||
| 2 | AstraZeneca PLC | 0.68 | 0.68 | 0.68 | |
| 3 | 0.76 | 0.60 | 0.58 | ||
| 4 | 0.57 | 0.58 | 0.54 | ||
| 5 | 0.74 | 0.63 | 0.52 | ||
| 6 | 0.63 | 0.52 | 0.47 | ||
| 7 | 0.64 | 0.54 | 0.44 | ||
| 8 | -0.19 | 0.23 | 0.43 | ||
| 9 | Sun Pharmaceutical Inds | 0.65 | 0.57 | 0.43 | |
| 10 | 0.51 | 0.45 | 0.43 | ||
| 11 | 0.48 | 0.44 | 0.42 | ||
| 12 | -0.37 | 0.25 | 0.42 | ||
| 13 | -0.01 | 0.20 | 0.39 | ||
| 14 | 0.66 | 0.31 | 0.37 | ||
| 15 | 0.54 | 0.48 | 0.37 | ||
| 16 | -0.20 | 0.36 | 0.36 | ||
| 17 | 0.64 | 0.48 | 0.36 | ||
| 18 | -0.23 | 0.09 | 0.36 | ||
| 19 | 0.57 | 0.55 | 0.36 | ||
| 20 | 0.69 | 0.63 | 0.35 | ||
| 21 | Torrent Pharmaceuticals | -0.21 | -0.20 | 0.33 | |
| 22 | 0.33 | 0.10 | 0.33 | ||
| 23 | 0.20 | 0.20 | 0.31 | ||
| 24 | -0.04 | 0.18 | 0.31 | ||
| 25 | Cipla | 0.49 | 0.25 | 0.30 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | SUSE | -0.13 | 0.04 | — | |
| 2 | DKSH Holding AG | — | — | — | |
| 3 | -0.15 | -0.36 | — | ||
| 4 | Daiichi Sankyo Company, Limited | 0 | 0.05 | — | |
| 5 | Ono Pharmaceutical Co., Ltd. | — | — | — | |
| 6 | -0.45 | -0.32 | — | ||
| 7 | -0.58 | -0.50 | — | ||
| 8 | 0.59 | — | — | ||
| 9 | -0.29 | — | — | ||
| 10 | Urovant Sciences Ltd. | 0.38 | — | — | |
| 11 | MediPal Holdings Corporation | — | — | — | |
| 12 | -0.08 | 0.13 | — | ||
| 13 | -0.38 | -0.43 | — | ||
| 14 | -0.32 | -0.03 | — | ||
| 15 | -0.48 | -0.40 | — | ||
| 16 | Ikena Oncology | -0.47 | -0.42 | — | |
| 17 | Meltwater | -0.46 | -0.46 | — | |
| 18 | -0.48 | 0.14 | — | ||
| 19 | Alfresa Holdings Corporation | — | — | — | |
| 20 | Bayer Aktiengesellschaft | 0.68 | 0.26 | — | |
| 21 | Vivendi SE | -0.20 | -0.54 | — | |
| 22 | Sumitomo Dainippon Pharma Co., Ltd. | — | — | — | |
| 23 | Astellas Pharma Inc. | -0.41 | — | — | |
| 24 | 0.46 | 0.13 | — | ||
| 25 | -0.48 | -0.40 | — | ||
| 26 | -0.31 | -0.44 | — | ||
| 27 | FUJIFILM Holdings Corporation | 0.36 | — | — | |
| 28 | -0.50 | -0.44 | — | ||
| 29 | -0.20 | -0.37 | — | ||
| 30 | H. Lundbeck A/S | -0.49 | -0.41 | — | |
| 31 | Asymchem Laboratories (Tianjin) H | — | — | — | |
| 32 | -0.32 | 0.42 | — | ||
| 33 | Eisai Co., Ltd. | — | — | — | |
| 34 | 0.06 | -0.32 | — | ||
| 35 | Atlantic Power Corporation | 0.47 | 0.41 | — | |
| 36 | Sanofi | 0.32 | 0.41 | — | |
| 37 | -0.66 | — | — | ||
| 38 | -0.59 | -0.58 | -0.64 | ||
| 39 | -0.50 | -0.59 | -0.59 | ||
| 40 | -0.29 | -0.47 | -0.58 | ||
| 41 | -0.39 | -0.46 | -0.56 | ||
| 42 | -0.35 | -0.36 | -0.55 | ||
| 43 | -0.04 | -0.38 | -0.54 | ||
| 44 | -0.23 | -0.39 | -0.54 | ||
| 45 | Onxeo | -0.21 | -0.45 | -0.54 | |
| 46 |  Hui Xian Real Est Invt Tr | -0.67 | -0.58 | -0.53 | |
| 47 | Nicox | -0.41 | -0.46 | -0.53 | |
| 48 | -0.32 | -0.41 | -0.53 | ||
| 49 | ADL Bionatur Solutions | -0.31 | -0.30 | -0.53 | |
| 50 | -0.44 | -0.44 | -0.53 | ||
| 51 | -0.31 | -0.51 | -0.52 | ||
| 52 | -0.65 | -0.48 | -0.51 | ||
| 53 | -0.43 | -0.47 | -0.51 | ||
| 54 | -0.39 | -0.36 | -0.49 | ||
| 55 | -0.49 | -0.51 | -0.48 | ||
| 56 | -0.54 | -0.47 | -0.48 | ||
| 57 | -0.28 | -0.40 | -0.48 | ||
| 58 | Generex Biotechnology | -0.42 | -0.45 | -0.47 | |
| 59 | 0 | -0.35 | -0.47 | ||
| 60 | 0.26 | -0.24 | -0.47 | ||
| 61 | -0.45 | -0.51 | -0.46 | ||
| 62 | Open Orphan | -0.29 | -0.49 | -0.46 | |
| 63 | -0.47 | -0.45 | -0.45 | ||
| 64 | -0.33 | -0.42 | -0.45 | ||
| 65 | -0.06 | -0.41 | -0.44 | ||
| 66 | -0.37 | -0.39 | -0.44 | ||
| 67 | -0.27 | -0.30 | -0.43 | ||
| 68 | 0.05 | -0.27 | -0.42 | ||
| 69 | -0.27 | -0.34 | -0.41 | ||
| 70 | -0.49 | -0.37 | -0.40 | ||
| 71 | 0.03 | -0.38 | -0.40 | ||
| 72 | -0.39 | -0.46 | -0.39 | ||
| 73 | -0.37 | -0.36 | -0.39 | ||
| 74 | -0.27 | -0.43 | -0.39 | ||
| 75 | 0.20 | -0.35 | -0.38 | ||
| 76 | Yumanity Therapeutics | -0.28 | -0.42 | -0.37 | |
| 77 | 0.34 | -0.07 | -0.37 | ||
| 78 | -0.40 | -0.36 | -0.36 | ||
| 79 | -0.41 | -0.47 | -0.36 | ||
| 80 | -0.53 | -0.43 | -0.35 | ||
| 81 | -0.56 | -0.52 | -0.35 | ||
| 82 | -0.44 | -0.33 | -0.34 | ||
| 83 | -0.13 | -0.36 | -0.34 | ||
| 84 | -0.38 | -0.34 | -0.33 | ||
| 85 | -0.36 | -0.42 | -0.33 | ||
| 86 | 0.50 | 0.29 | -0.33 | ||
| 87 | -0.37 | -0.40 | -0.32 | ||
| 88 | -0.05 | -0.36 | -0.32 | ||
| 89 | -0.19 | -0.52 | -0.32 | ||
| 90 | 0.06 | -0.28 | -0.31 | ||
| 91 | -0.30 | -0.37 | -0.31 | ||
| 92 | 0.22 | 0.11 | -0.30 | ||
| 93 | 0.24 | -0.22 | -0.30 | ||
| 94 | -0.08 | -0.25 | -0.30 | ||
| 95 | -0.67 | -0.52 | -0.30 | ||
| 96 | -0.54 | -0.50 | -0.30 | ||
| 97 | -0.31 | -0.46 | -0.30 | ||
| 98 | -0.51 | -0.40 | -0.27 | ||
| 99 | -0.29 | -0.47 | -0.27 | ||
| 100 | -0.21 | -0.36 | -0.27 | ||
| 101 | -0.18 | -0.37 | -0.27 | ||
| 102 | -0.46 | -0.38 | -0.26 | ||
| 103 | -0.39 | -0.11 | -0.26 | ||
| 104 | -0.53 | -0.44 | -0.24 | ||
| 105 | 0.07 | -0.06 | -0.23 | ||
| 106 | 0.42 | 0.01 | -0.23 | ||
| 107 | -0.56 | -0.32 | -0.23 | ||
| 108 | 0.16 | -0.16 | -0.22 | ||
| 109 | -0.37 | -0.32 | -0.21 | ||
| 110 | -0.06 | -0.37 | -0.20 | ||
| 111 | -0.12 | -0.24 | -0.20 | ||
| 112 | 0.16 | 0.03 | -0.19 | ||
| 113 | Pharmaron Beijing H | -0.28 | -0.37 | -0.18 | |
| 114 | -0.35 | -0.36 | -0.18 | ||
| 115 | -0.32 | -0.39 | -0.18 | ||
| 116 | 0.38 | -0.21 | -0.17 | ||
| 117 | -0.13 | -0.25 | -0.16 | ||
| 118 | -0.26 | 0.06 | -0.16 | ||
| 119 | -0.52 | -0.42 | -0.16 | ||
| 120 | 0.53 | -0.27 | -0.16 | ||
| 121 | Aarti Drugs | -0.28 | -0.40 | -0.16 | |
| 122 | 0.29 | 0.34 | -0.15 | ||
| 123 | -0.45 | -0.40 | -0.15 | ||
| 124 | -0.19 | -0.26 | -0.14 | ||
| 125 | Dr. Reddy's Laboratories Ltd. | -0.17 | -0.35 | -0.14 | |
| 126 | -0.22 | -0.05 | -0.12 | ||
| 127 | -0.25 | -0.18 | -0.10 | ||
| 128 | -0.37 | -0.35 | -0.07 | ||
| 129 | -0.41 | -0.34 | -0.07 | ||
| 130 | Leap Therapeutics | -0.53 | -0.03 | -0.07 | |
| 131 | Vivimed Labs | -0.39 | -0.49 | -0.06 | |
| 132 | -0.34 | 0.05 | -0.04 | ||
| 133 | 0.72 | 0.19 | -0.03 | ||
| 134 | 0.60 | 0.40 | -0.02 | ||
| 135 | 0.07 | 0.10 | 0.02 | ||
| 136 | -0.18 | -0.35 | 0.02 | ||
| 137 | -0.43 | -0.35 | 0.03 | ||
| 138 | 0.18 | -0.04 | 0.04 | ||
| 139 | -0.27 | -0.28 | 0.05 | ||
| 140 | -0.36 | -0.22 | 0.06 | ||
| 141 | -0.37 | -0.27 | 0.06 | ||
| 142 | -0.43 | -0.03 | 0.06 | ||
| 143 | 0.05 | 0.04 | 0.06 | ||
| 144 | 0.71 | 0.30 | 0.07 | ||
| 145 | Eurofins Scientific SE | -0.38 | -0.34 | 0.07 | |
| 146 | -0.35 | -0.37 | 0.08 | ||
| 147 | 0.56 | 0.37 | 0.08 | ||
| 148 | -0.49 | -0.34 | 0.09 | ||
| 149 | 0.80 | 0.68 | 0.11 | ||
| 150 | -0.31 | -0.19 | 0.12 | ||
| 151 | 0.51 | -0.05 | 0.13 | ||
| 152 | -0.34 | -0.19 | 0.13 | ||
| 153 | -0.38 | -0.10 | 0.15 | ||
| 154 | -0.23 | -0.24 | 0.17 | ||
| 155 | 0.77 | 0.59 | 0.18 | ||
| 156 | -0.33 | -0.13 | 0.19 | ||
| 157 | 0 | -0.18 | 0.22 | ||
| 158 | -0.19 | 0.35 | 0.23 | ||
| 159 | -0.66 | -0.19 | 0.23 | ||
| 160 | -0.62 | -0.19 | 0.23 | ||
| 161 | 0.21 | 0.38 | 0.26 | ||
| 162 | -0.33 | 0.16 | 0.27 | ||
| 163 | -0.03 | 0.07 | 0.27 | ||
| 164 | Ultimovacs | -0.28 | 0.10 | 0.28 | |
| 165 | 0.67 | 0.52 | 0.29 | ||
| 166 | 0.67 | 0.36 | 0.29 |
Access this data via the Eulerpool API
Merck & Co Stock analysis
What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry.
Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this.
Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines.
Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol.
The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation".
Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals.
Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.
All Key Metrics — Merck & Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth